Subscribe To Our Free Newsletter |
Caplin Point rises on USFDA nod for eye drops
Caplin Point Laboratories added 1.67% to Rs 1,318.75 after its subsidiary, Caplin Steriles received final approval from the US drug regulator for its abbreviated new drug application (ANDA) Ofloxacin Ophthalmic Solution.